0 items

in your cart
$0.00

Prescription Drug Search

Product Request Form

Dalfampridine is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Dalfampridine becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Dalfampridine:

  • Albania
  • Algeria
  • Antigua and Barbuda
  • Aruba
  • Australia
  • Bangladesh
  • Barbados
  • Belgium
  • Belize
  • Bulgaria
  • Cayman Islands
  • China
  • Cuba
  • Czech Republic
  • European Union
  • Finland
  • Grenada
  • Honduras
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Italy
  • Korea, Republic of
  • Korea, South
  • Latvia
  • Luxembourg
  • Malta
  • Norway
  • Qatar
  • Romania
  • Russian Federation
  • Seychelles
  • Slovenia
  • Spain
  • Sri Lanka
  • Thailand
  • Trinidad and Tobago
  • Tunisia
  • United Kingdom, UK
View All Countries

Latest news releases on Dalfampridine:

6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth - Seekingalpha.com

The company's marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

6 High-Growth Biotechnology Stocks With Great Liquidity - Seekingalpha.com

Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with MS; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity.

Alkermes plc Reports Results for Fiscal 2012 and Provides Expectations for Fiscal 2013 - PharmiWeb

1AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg is developed and marketed in the U.S. by Acorda Therapeutics, Inc. and outside the U.S. by Biogen Idec, under a licensing agreement with Acorda Therapeutics, as FAMPYRA® (prolonged-release fampridine tablets).

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK